• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

New Drugs

Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
  • offers treatment for a disease for which no specific therapy previously existed
  • targets a new therapeutic target
  • has a new mechanism of action
  • is developed in a new formulation, optimized or improved
  • is part of a new combination drug
  • belongs to a new class of drug compounds.
cytomegalovirus
Posted inInfections, New Drugs, Regulatory

Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection

by Tanya von Reuss December 4, 2021September 8, 2022

Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.

PEComa
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Fyarro: First Drug to Treat Perivascular Epithelioid Cell Tumor

by Tanya von Reuss December 4, 2021September 8, 2022

PEComa is a very rare and aggressive subtype of soft tissue sarcoma.

StrataGraft
Posted inNew Drugs, Regulatory

StrataGraft: Artificial Skin for Treatment of Severe Thermal Burns

by Tanya von Reuss December 4, 2021September 8, 2022

Mallinckrodt has offered an effective alternative to autograft procedures.

Pneumonia
Posted inInfections, New Drugs, Regulatory

Prevnar 20: New Pneumococcal Vaccine

by Mark Gubar November 13, 2021April 11, 2024

Pfizer has released an updated and improved version of Prevnar 13, a popular pneumococcal vaccine.

molnupiravir
Posted inCOVID-19, Infections, New Drugs, Regulatory

Lagevrio: New Antiviral Drug to Treat COVID-19

by Julia Mardi November 4, 2021September 8, 2022

The oral antiviral drug molnupiravir by Merck & Co.

obesity
Posted inMetabolism, New Drugs, Regulatory

Wegovy: Most Effective Drug for Weight Loss

by Nik Resovski and Timur Burkhanayev June 9, 2021September 8, 2022

Semaglutide can help you lose 15% of your excess weight in a year. And even more.

Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory

Kesimpta: Highly Effective New Drug for Multiple Sclerosis

by Julia Mardi June 4, 2021September 8, 2022

Ofatumumab by Novartis is as good and convenient as Ocrevus by Roche against multiple sclerosis.

Posts pagination

Newer posts 1 … 8 9 10 11 12 13 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×